BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17341662)

  • 1. Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study.
    Whitman SP; Ruppert AS; Marcucci G; Mrózek K; Paschka P; Langer C; Baldus CD; Wen J; Vukosavljevic T; Powell BL; Carroll AJ; Kolitz JE; Larson RA; Caligiuri MA; Bloomfield CD
    Blood; 2007 Jun; 109(12):5164-7. PubMed ID: 17341662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The initial level of MLL-partial tandem duplication affects the clinical outcomes in patients with acute myeloid leukemia.
    Kong J; Zhao XS; Qin YZ; Zhu HH; Jia JS; Jiang Q; Wang J; Zhao T; Huang XJ; Jiang H
    Leuk Lymphoma; 2018 Apr; 59(4):967-972. PubMed ID: 28745571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm.
    Döhner K; Tobis K; Ulrich R; Fröhling S; Benner A; Schlenk RF; Döhner H
    J Clin Oncol; 2002 Aug; 20(15):3254-61. PubMed ID: 12149299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.
    Steudel C; Wermke M; Schaich M; Schäkel U; Illmer T; Ehninger G; Thiede C
    Genes Chromosomes Cancer; 2003 Jul; 37(3):237-51. PubMed ID: 12759922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MLL partial tandem duplication in acute myeloid leukaemia.
    Basecke J; Whelan JT; Griesinger F; Bertrand FE
    Br J Haematol; 2006 Nov; 135(4):438-49. PubMed ID: 16965385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells.
    Muñoz L; Nomdedéu JF; Villamor N; Guardia R; Colomer D; Ribera JM; Torres JP; Berlanga JJ; Fernández C; Llorente A; Queipo de Llano MP; Sánchez JM; Brunet S; Sierra J;
    Leukemia; 2003 Jan; 17(1):76-82. PubMed ID: 12529663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tandem duplications of MLL and FLT3 are correlated with poor prognoses in pediatric acute myeloid leukemia: a study of the Japanese childhood AML Cooperative Study Group.
    Shimada A; Taki T; Tabuchi K; Taketani T; Hanada R; Tawa A; Tsuchida M; Horibe K; Tsukimoto I; Hayashi Y
    Pediatr Blood Cancer; 2008 Feb; 50(2):264-9. PubMed ID: 17763464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of additional gene mutations in acute myeloid leukemia with MLL partial tandem duplication: DNMT3A mutation is associated with poor prognosis.
    Kao HW; Liang DC; Kuo MC; Wu JH; Dunn P; Wang PN; Lin TL; Shih YS; Liang ST; Lin TH; Lai CY; Lin CH; Shih LY
    Oncotarget; 2015 Oct; 6(32):33217-25. PubMed ID: 26375248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement.
    Shih LY; Liang DC; Fu JF; Wu JH; Wang PN; Lin TL; Dunn P; Kuo MC; Tang TC; Lin TH; Lai CL
    Leukemia; 2006 Feb; 20(2):218-23. PubMed ID: 16341046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy.
    Whitman SP; Liu S; Vukosavljevic T; Rush LJ; Yu L; Liu C; Klisovic MI; Maharry K; Guimond M; Strout MP; Becknell B; Dorrance A; Klisovic RB; Plass C; Bloomfield CD; Marcucci G; Caligiuri MA
    Blood; 2005 Jul; 106(1):345-52. PubMed ID: 15774615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD).
    Sun QY; Ding LW; Tan KT; Chien W; Mayakonda A; Lin DC; Loh XY; Xiao JF; Meggendorfer M; Alpermann T; Garg M; Lim SL; Madan V; Hattori N; Nagata Y; Miyano S; Yeoh AE; Hou HA; Jiang YY; Takao S; Liu LZ; Tan SZ; Lill M; Hayashi M; Kinoshita A; Kantarjian HM; Kornblau SM; Ogawa S; Haferlach T; Yang H; Koeffler HP
    Leukemia; 2017 Jan; 31(1):1-10. PubMed ID: 27389053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MLL-PTD in a 13-year-old patient with blast phase myeloproliferative neoplasm: A case report.
    He Z; Wang B; Chen L; Huang Y; Wang H; Yang M; Xiao X; Lu Y; Chen J; Wu Y
    Medicine (Baltimore); 2018 Nov; 97(46):e13220. PubMed ID: 30431598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia.
    Nasilowska-Adamska B; Solarska I; Paluszewska M; Malinowska I; Jedrzejczak WW; Warzocha K
    Ann Hematol; 2014 Apr; 93(4):577-93. PubMed ID: 24030729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cells.
    Zhang Y; Yan X; Sashida G; Zhao X; Rao Y; Goyama S; Whitman SP; Zorko N; Bernot K; Conway RM; Witte D; Wang QF; Tenen DG; Xiao Z; Marcucci G; Mulloy JC; Grimes HL; Caligiuri MA; Huang G
    Blood; 2012 Aug; 120(5):1118-29. PubMed ID: 22740449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse kinetics in acute myeloid leukaemias with MLL translocations or partial tandem duplications within the MLL gene.
    Ommen HB; Hokland P; Haferlach T; Abildgaard L; Alpermann T; Haferlach C; Kern W; Schnittger S
    Br J Haematol; 2014 Jun; 165(5):618-28. PubMed ID: 24611505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23.
    Shiah HS; Kuo YY; Tang JL; Huang SY; Yao M; Tsay W; Chen YC; Wang CH; Shen MC; Lin DT; Lin KH; Tien HF
    Leukemia; 2002 Feb; 16(2):196-202. PubMed ID: 11840285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of MLL rearrangement in acute myeloid leukemia, and a CALM-AF10 fusion in M4 type acute myeloblastic leukemia.
    Abdou SM; Jadayel DM; Min T; Swansbury GJ; Dainton MG; Jafer O; Powles RL; Catovsky D
    Leuk Lymphoma; 2002 Jan; 43(1):89-95. PubMed ID: 11911106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML.
    Schnittger S; Kinkelin U; Schoch C; Heinecke A; Haase D; Haferlach T; Büchner T; Wörmann B; Hiddemann W; Griesinger F
    Leukemia; 2000 May; 14(5):796-804. PubMed ID: 10803509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a novel childhood acute myeloid leukaemia cell line, KOPM-88, containing partial tandem duplication of the MLL gene and an in vivo model for childhood acute myeloid leukaemia using NOD/SCID mice.
    Hayashi M; Kondoh K; Nakata Y; Kinoshita A; Mori T; Takahashi T; Sakamoto MI; Yamada T
    Br J Haematol; 2007 May; 137(3):221-32. PubMed ID: 17408461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk assessment by monitoring expression levels of partial tandem duplications in the MLL gene in acute myeloid leukemia during therapy.
    Weisser M; Kern W; Schoch C; Hiddemann W; Haferlach T; Schnittger S
    Haematologica; 2005 Jul; 90(7):881-9. PubMed ID: 15996925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.